Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Yahi

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Toxicon : Official Journal of the International Society on Toxinology|July 1, 1992
Monoclonal antibodies to toxin II from the scorpion Androctonus australis Hector: further characterization of epitope specificities and neutralizing capacitiesN Yahi, C Devaux, P Mansuelle, et al.
The Journal of Infectious Diseases|April 11, 2001
Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scaleN Yahi, J Fantini, C Tourres, et al.
Methods in Enzymology|November 9, 2000
Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactionsD Hammache, G Piéroni, M Maresca, et al.
Virology|July 11, 1998
Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cellsJ Fantini, D Hammache, O Delézay, et al.
Journal of Virology|January 1, 1995
Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell lineN Yahi, J M Sabatier, S Baghdiguian, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 6, 1998
HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infectionJ Fantini, C Tamalet, D Hammache, et al.
Virus Research|October 1, 1994
Physical contact with lymphocytes is required for reactivation of dormant HIV-1 in colonic epithelial cells: involvement of the HIV-1 LTRE Faure, N Yahi, A Zider, et al.
Biochemical and Biophysical Research Communications|May 26, 1998
Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactorsD Hammache, N Yahi, G Piéroni, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variantN Koch, J B Ndihokubwayo, N Yahi, et al.
AIDS (London, England)|March 1, 1994
Inefficacy of neutralizing antibodies against autologous lymph-node HIV-1 isolates in patients with early-stage HIV infectionC Tamalet, A Lafeuillade, C Tourres, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Toxicon : Official Journal of the International Society on Toxinology|July 1, 1992
Monoclonal antibodies to toxin II from the scorpion Androctonus australis Hector: further characterization of epitope specificities and neutralizing capacitiesN Yahi, C Devaux, P Mansuelle, et al.
The Journal of Infectious Diseases|April 11, 2001
Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scaleN Yahi, J Fantini, C Tourres, et al.
Methods in Enzymology|November 9, 2000
Reconstitution of sphingolipid-cholesterol plasma membrane microdomains for studies of virus-glycolipid interactionsD Hammache, G Piéroni, M Maresca, et al.
Virology|July 11, 1998
Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cellsJ Fantini, D Hammache, O Delézay, et al.
Journal of Virology|January 1, 1995
Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell lineN Yahi, J M Sabatier, S Baghdiguian, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|November 6, 1998
HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infectionJ Fantini, C Tamalet, D Hammache, et al.
Virus Research|October 1, 1994
Physical contact with lymphocytes is required for reactivation of dormant HIV-1 in colonic epithelial cells: involvement of the HIV-1 LTRE Faure, N Yahi, A Zider, et al.
Biochemical and Biophysical Research Communications|May 26, 1998
Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactorsD Hammache, N Yahi, G Piéroni, et al.
AIDS Research and Human Retroviruses|February 15, 2001
Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variantN Koch, J B Ndihokubwayo, N Yahi, et al.
AIDS (London, England)|March 1, 1994
Inefficacy of neutralizing antibodies against autologous lymph-node HIV-1 isolates in patients with early-stage HIV infectionC Tamalet, A Lafeuillade, C Tourres, et al.
Pageof 6